FIELD: medicine, pharmaceutics.
SUBSTANCE: there are described new benzodiazepine compounds of general formula , wherein each R1, R2, R3 and R4 independently represent hydrogen or alkyl, or R2 and R3 together represent lower alkylene; A1 is lower alkylene optionally substituted by hydroxy; and R5 is a fragment of formula , wherein each R6 and R7 independently represents hydrogen, lower alkyl, cycloalkyl, phenyl, furyl, thienyl, pyrazolyl, etc.; each XA and XB independently represents a bond, lower alkylene, -CO-, -SO2- etc., a pharmaceutical composition containing them, and using the above compound as the pharmaceutical composition or for preparing the same.
EFFECT: new compounds may be used for preventing and treating cardiac arrhythmia.
8 cl, 1047 ex, 78 tbl
Title | Year | Author | Number |
---|---|---|---|
HETEROCYCLIC INHIBITORS OF Hh-SYGNAL CASCADE, BASED ON THEM MEDICINAL COMPOSITIONS AND METHOD OF TREATING DISEASES INDUCED BY ABBARANT ACTIVITY OF Hh-SIGNAL SYSTEM | 2007 |
|
RU2364597C1 |
MODULATORS OF ADENOSINE RECEPTORS | 2001 |
|
RU2277911C2 |
HETEROCYCLYLSULFINIC ACIDS AND THEIR DERIVATIVES, FOCUSED LIBRARY AND PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2263666C1 |
METHOD OF OBTAINING BENZO[b][1,4]DIAZEPINE-2,4-DIONE DERIVATIVE | 2010 |
|
RU2553676C2 |
CARBOSTYRIL COMPOUND | 2005 |
|
RU2430920C2 |
DERIVATIVES OF BENZODIAZEPINE, MEDICINAL AGENT COMPRISING THEREOF AND METHOD FOR THEIR PREPARING | 2000 |
|
RU2257382C2 |
COMBINATIONS CONTAININS Bcr-Abl/c-Kit/PDGF-RTK INHIBITORS FOR TREATING CANCER | 2007 |
|
RU2452492C2 |
IMIDES BASED PROTEOLYSIS MODULATORS AND RELATED METHODS OF USE | 2016 |
|
RU2704807C2 |
SUBSTITUTED 7-SULFONYL-BENZO[B][1,4]DIAZEPINES (VARIANTS), METHODS FOR THEIR PREPARING (VARIANTS), FOCUSED LIBRARY AND PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2261246C1 |
1,3-DISUBSTITUTED 4-METHYL-1H-PYRROL-2-CARBOXAMIDES AND USE THEREOF FOR PREPARING DRUGS | 2007 |
|
RU2463294C2 |
Authors
Dates
2013-10-27—Published
2009-02-20—Filed